erythrosine has been researched along with tetrandrine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chiou, GC; Xiao, JG | 1 |
Choy, E; Duan, Z; Hornicek, F; Mankin, H; Schwab, J; Susa, M; Yang, C | 1 |
2 other study(ies) available for erythrosine and tetrandrine
Article | Year |
---|---|
Tetrandrine inhibits breakdown of blood-aqueous barrier induced by endotoxin and interleukin-1 alpha in rats.
Topics: Alkaloids; Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzylisoquinolines; Blood-Aqueous Barrier; Dose-Response Relationship, Drug; Endotoxins; Female; Fluorescein; Fluoresceins; Fluorophotometry; Immunosuppressive Agents; Interleukin-1; Rats; Rats, Sprague-Dawley; Uveitis, Posterior | 1996 |
Multidrug resistance reversal agent, NSC77037, identified with a cell-based screening assay.
Topics: Adenosine Triphosphatases; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzylisoquinolines; Cell Line, Tumor; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Fluoresceins; Humans; Paclitaxel; Substrate Specificity; Time Factors; Verapamil | 2010 |